Prescient NeuroPharma Inc.

April 09, 2007 09:00 ET

Prescient NeuroPharma Inc.: Settlement of Debt and Judgment

VANCOUVER, BRITISH COLUMBIA--(CCNMatthews - April 9, 2007) - Prescient NeuroPharma Inc. (the "Company") (TSX VENTURE:PNO) announces that it has entered into a debt settlement and forgiveness agreement with each of its long term debt holders pursuant to which each of the debt holders have agreed to settle all outstanding debt for nominal consideration. The Company also announces that it has come to settlement terms with Marusyk Miller & Swain LLP/MBM & Co with respect to its outstanding judgment against the Company.

The Company intends to use the proceeds of its recently announced private placement to explore for new opportunities and acquisitions in the natural resource sector.

Leanne Bate, President & CEO

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this press release.

Contact Information

  • Prescient NeuroPharma Inc.
    Leanne Bate
    President & CEO
    (604) 808-3570